231 related articles for article (PubMed ID: 31655957)
1. Age-related alterations of articular cartilage in pituitary adenylate cyclase-activating polypeptide (PACAP) gene-deficient mice.
Szegeczki V; Bauer B; Jüngling A; Fülöp BD; Vágó J; Perényi H; Tarantini S; Tamás A; Zákány R; Reglődi D; Juhász T
Geroscience; 2019 Dec; 41(6):775-793. PubMed ID: 31655957
[TBL] [Abstract][Full Text] [Related]
2. Signalling Alterations in Bones of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Gene Deficient Mice.
Józsa G; Szegeczki V; Pálfi A; Kiss T; Helyes Z; Fülöp B; Cserháti C; Daróczi L; Tamás A; Zákány R; Reglődi D; Juhász T
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150589
[No Abstract] [Full Text] [Related]
3. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
[TBL] [Abstract][Full Text] [Related]
4. Current knowledge of pituitary adenylate cyclase activating polypeptide (PACAP) in articular cartilage.
Lauretta G; Ravalli S; Szychlinska MA; Castorina A; Maugeri G; D'Amico AG; D'Agata V; Musumeci G
Histol Histopathol; 2020 Nov; 35(11):1251-1262. PubMed ID: 32542641
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase activating polypeptide (PACAP) signalling exerts chondrogenesis promoting and protecting effects: implication of calcineurin as a downstream target.
Juhász T; Matta C; Katona É; Somogyi C; Takács R; Gergely P; Csernoch L; Panyi G; Tóth G; Reglődi D; Tamás A; Zákány R
PLoS One; 2014; 9(3):e91541. PubMed ID: 24643018
[TBL] [Abstract][Full Text] [Related]
6. Accelerated retinal aging in PACAP knock-out mice.
Kovács-Valasek A; Szabadfi K; Dénes V; Szalontai B; Tamás A; Kiss P; Szabó A; Setalo G; Reglődi D; Gábriel R
Neuroscience; 2017 Apr; 348():1-10. PubMed ID: 28215987
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characterization of testicular immune cells expressing immune checkpoint molecules in wild-type and pituitary adenylate cyclase-activating polypeptide-deficient mice.
Meggyes M; Lajko A; Fulop BD; Reglodi D; Szereday L
Am J Reprod Immunol; 2020 Mar; 83(3):e13212. PubMed ID: 31758623
[TBL] [Abstract][Full Text] [Related]
8. Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.
Ivic I; Solymar M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D
J Vasc Res; 2017; 54(6):359-366. PubMed ID: 29131060
[TBL] [Abstract][Full Text] [Related]
9. Lack of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Disturbs Callus Formation.
Józsa G; Fülöp BD; Kovács L; Czibere B; Szegeczki V; Kiss T; Hajdú T; Tamás A; Helyes Z; Zákány R; Reglődi D; Juhász T
J Mol Neurosci; 2021 Aug; 71(8):1543-1555. PubMed ID: 31808034
[TBL] [Abstract][Full Text] [Related]
10. PAC1 deficiency reduces chondrogenesis in atherosclerotic lesions of hypercholesterolemic ApoE-deficient mice.
Blümm C; Bonaterra GA; Schwarzbach H; Eiden LE; Weihe E; Kinscherf R
BMC Cardiovasc Disord; 2023 Nov; 23(1):566. PubMed ID: 37980508
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
Li M; Funahashi H; Mbikay M; Shioda S; Arimura A
Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198
[TBL] [Abstract][Full Text] [Related]
12. Hearing impairment and associated morphological changes in pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.
Fulop DB; Humli V; Szepesy J; Ott V; Reglodi D; Gaszner B; Nemeth A; Szirmai A; Tamas L; Hashimoto H; Zelles T; Tamas A
Sci Rep; 2019 Oct; 9(1):14598. PubMed ID: 31601840
[TBL] [Abstract][Full Text] [Related]
13. Accelerated pre-senile systemic amyloidosis in PACAP knockout mice - a protective role of PACAP in age-related degenerative processes.
Reglodi D; Jungling A; Longuespée R; Kriegsmann J; Casadonte R; Kriegsmann M; Juhasz T; Bardosi S; Tamas A; Fulop BD; Kovacs K; Nagy Z; Sparks J; Miseta A; Mazzucchelli G; Hashimoto H; Bardosi A
J Pathol; 2018 Aug; 245(4):478-490. PubMed ID: 29774542
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor 1 (PAC1) in the human infant brain and changes in the Sudden Infant Death Syndrome (SIDS).
Huang J; Waters KA; Machaalani R
Neurobiol Dis; 2017 Jul; 103():70-77. PubMed ID: 28392470
[TBL] [Abstract][Full Text] [Related]
15. Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Reduces Oxidative and Mechanical Stress-Evoked Matrix Degradation in Chondrifying Cell Cultures.
Szentléleky E; Szegeczki V; Karanyicz E; Hajdú T; Tamás A; Tóth G; Zákány R; Reglődi D; Juhász T
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621194
[TBL] [Abstract][Full Text] [Related]
16. Pituitary Adenylate Cyclase-activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia-Reperfusion Injury.
Liu Y; Lu T; Zhang C; Xue Z; Xu J; Busuttil RW; Xia Q; Xu N; Kupiec-Weglinski JW; Ji H
Transplantation; 2019 Aug; 103(8):1639-1648. PubMed ID: 31348437
[TBL] [Abstract][Full Text] [Related]
17. Altered Notch Signaling in Developing Molar Teeth of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)-Deficient Mice.
Fulop BD; Sandor B; Szentleleky E; Karanyicz E; Reglodi D; Gaszner B; Zakany R; Hashimoto H; Juhasz T; Tamas A
J Mol Neurosci; 2019 Jul; 68(3):377-388. PubMed ID: 30094580
[TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stem/stromal cells suppress spinal inflammation in mice with contribution of pituitary adenylate cyclase-activating polypeptide (PACAP).
Tsumuraya T; Ohtaki H; Song D; Sato A; Watanabe J; Hiraizumi Y; Nakamachi T; Xu Z; Dohi K; Hashimoto H; Atsumi T; Shioda S
J Neuroinflammation; 2015 Feb; 12():35. PubMed ID: 25889720
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
[TBL] [Abstract][Full Text] [Related]
20. Convergent phosphomodulation of the major neuronal dendritic potassium channel Kv4.2 by pituitary adenylate cyclase-activating polypeptide.
Gupte RP; Kadunganattil S; Shepherd AJ; Merrill R; Planer W; Bruchas MR; Strack S; Mohapatra DP
Neuropharmacology; 2016 Feb; 101():291-308. PubMed ID: 26456351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
